Letrozole Tablet, Film Coated
Product Images NDC 71205-587

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 71205-587). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sturctural Formula Of Letrozole (Image 1)

Chemical structure diagram of letrozole showing its molecular composition with nitrogen-containing rings and cyano groups attached to phenyl rings.*

FDA Label Image

Figure01 (Image 2)

A survival curve graph comparing Letrozole and Tamoxifen treatments over 72 months. The y-axis ranges from 0.0 to 1.0, and the x-axis represents months from 0 to 72. The solid line represents Letrozole treatment, and the dashed line represents Tamoxifen. Patient numbers and event rates are shown below the graph, indicating sample sizes and censored patients for each treatment group across the study duration.*

FDA Label Image

Figure02 (Image 3)

A progression-free survival curve comparing Letrozole 2.5 mg and Tamoxifen 20 mg over a 60-month period. The y-axis represents progression-free proportion, and the x-axis shows time in months. The graph includes a solid line for Letrozole 2.5 mg and a dashed line for Tamoxifen 20 mg.*

FDA Label Image

Figure03 (Image 4)

A line graph comparing survival outcomes over time for Letrozole and Tamoxifen treatments. The x-axis represents months from 0 to 60, and the y-axis shows the proportion alive from 0.0 to 1.0. Two curves are shown: a solid line for Letrozole and a dashed line for Tamoxifen, illustrating survival trends over the follow-up period.*

FDA Label Image

Figure04 (Image 5)

A survival curve chart depicting time to progression in days on the x-axis and proportion on the y-axis for three treatment groups: Letrozole 0.5 mg, Letrozole 2.5 mg, and MA.*

FDA Label Image

Figure05 (Image 6)

A survival curve chart depicting time to progression in days for three treatment groups: Letrozole 0.5 mg, Letrozole 2.5 mg, and AG. The x-axis represents time in days up to 1000, while the y-axis shows progression proportion from 0 to 1. Lines with different styles correspond to each treatment group.*

FDA Label Image

71205-587-30 (Image 7)

Letrozole 2.5 mg film-coated tablets label by Proficient Rx LP, indicating 30 tablets per bottle. The label specifies the active ingredient strength, tablet description, product ID SL058730, manufacture details by TEVA Pharmaceutical Industries, and storage instructions. Includes QR code, lot, and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.